Liposomal Irinotecan + Oxaliplatin + Bevacizumab Versus Liposomal Irinotecan + 5-FU/LV

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Advanced Pancreatic Cancer (Part 1)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • Beijing, Beijing, China

  • Chinese PLA General Hospital, Beijing, China

    Contact: Study coordinator (Guanghai Dai) · daigh60@sohu.com · 13801232381